Therapy: Conclusive remarks

Paolo Alboni, Raffaello Furlan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The course of vasovagal syncope (VVS) is benign, but when it is recurrent, it may be highly symptomatic, leading to significant deterioration of quality of life with psychological, driving, and employment implications [1]. Therefore, every treatment can be addressed only to improve quality of life and not to prolong survival. Patients seeking medical assistance after experiencing an episode of VVS often undergo costly diagnostic examinations and are anxious and concerned about the possibility to be at increased risk of dying or suffering from a myocardial infarction or stroke. Therefore, priority should be given to patient’s reassurance about the benign nature of VVS. There are no evidence-based data on the effects of such a reassurance, but clinical experience suggests that a convincing advice often improves the quality of life of patients with recurrent VVS. Conventional therapy of VVS includes lifestyle modification, pharmacological treatment, and cardiac pacing.

Original languageEnglish
Title of host publicationVasovagal Syncope
PublisherSpringer International Publishing
Pages255-267
Number of pages13
ISBN (Print)9783319091020, 9783319091013
DOIs
Publication statusPublished - Jan 1 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Therapy: Conclusive remarks'. Together they form a unique fingerprint.

  • Cite this

    Alboni, P., & Furlan, R. (2015). Therapy: Conclusive remarks. In Vasovagal Syncope (pp. 255-267). Springer International Publishing. https://doi.org/10.1007/978-3-319-09102-0_21